title: The current status of polycystic ovary syndrome.
abstract: The importance of polycystic ovary syndrome (PCOS) has recently received much publicity. Whereas previously it was thought simply to be a disorder which was characterised by irregular ovulation, there is now evidence to show that it is a systemic metabolic disease determined genetically and inherited. As well as treating the presenting problem which, for gynaecologists is usually one of irregular menstruation and anovulation, or sometimes signs of hyperandrogenism, we believe that women should also be screened for their lipid status and insulin resistance. Advice on behaviour modification such as increased exercise and dietary adjustment should be recommended in addition to the treatment for ovulation induction. In the future, the use of insulin sensitising agents may become important in the treatment of PCOS.
authors: Monash IVF, Melbourne, Victoria, Australia.
authors: G
authors: G
authors: Kovacs
authors: C
authors: C
authors: Wood
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D015444:Exercise; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods / Q000639:trends; D005544:Forecasting; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology / Q000517:prevention & control; D007333:Insulin Resistance; D008019:Life Style; D008403:Mass Screening / Q000379:methods / Q000639:trends; D010062:Ovulation Induction / Q000379:methods / Q000639:trends; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D011379:Prognosis; D012307:Risk Factors